Prostaglandin E1 in neonates with critical congenital heart disease.
作者信息
Dungan W T, Norton J B, Readinger R I, Sotomora R F
出版信息
J Ark Med Soc. 1982 Oct;79(5):167-70.
PMID:6183249
Abstract
摘要
相似文献
1
Prostaglandin E1 in neonates with critical congenital heart disease.前列腺素E1在患有严重先天性心脏病的新生儿中的应用
J Ark Med Soc. 1982 Oct;79(5):167-70.
2
Prostaglandins and the management of congenital heart disease.前列腺素与先天性心脏病的治疗
Am Fam Physician. 1982 Dec;26(6):127-32.
3
Role of prostaglandin E1 and E2 in the management of neonatal heart disease.前列腺素E1和E2在新生儿心脏病治疗中的作用。
Adv Prostaglandin Thromboxane Res. 1978;4:345-53.
4
5
Prostaglandin E1 infusion: successful initial treatment.前列腺素E1输注：初始治疗成功
N Y State J Med. 1981 Feb;81(2):218-21.
6
[Value of prostaglandin E1 in cardiac malformations in the newborn infant].[前列腺素E1在新生儿心脏畸形中的价值]
Pediatrie. 1984 Jun;39(4):245-52.
7
[Prostaglandin treatment of ductus-dependent congenital heart defects].[前列腺素治疗依赖动脉导管的先天性心脏缺陷]
Lakartidningen. 1984 Oct 3;81(40):3619-22.
8
Effects of prostaglandins and blockers of prostaglandin synthesis on the ductus arteriosus: animal and human studies.前列腺素及前列腺素合成阻滞剂对动脉导管的影响：动物及人体研究
Adv Prostaglandin Thromboxane Res. 1978;4:363-72.
9
Prostaglandin E1 in infants with critical congenital heart disease.
Gaoxiong Yi Xue Ke Xue Za Zhi. 1985 Jan;1(1):71-4.
10
Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.给予前列腺素E1治疗动脉导管依赖性先天性心脏病后动脉导管的形态学特征。
J Am Coll Cardiol. 1983 Feb;1(2 Pt 1):471-5. doi: 10.1016/s0735-1097(83)80075-8.
Zotero 插件